Luis R. Nassar

Luis R. Nassar

Auto-generated profile, based on publicly available information

Luis R. Nassar

Genomics Institute, University of California Santa Cruz , Santa Cruz, CA 95064

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
GPGerardo Perez
Gerardo Perez
GBGalt P Barber
Galt P Barber
ABAnna Benet-Pages
Anna Benet-Pages
JCJonathan Casper
Jonathan Casper
HCHiram Clawson
Hiram Clawson
MHMaximilian Haeussler
Maximilian Haeussler
The UCSC Genome Browser (https://genome.ucsc.edu) is a widely utilized web-based tool for visualization and analysis of genomic data, encompassing over 4000 assemblies from diverse organisms. Since its release in 2001, it has become an essential resource for genomics and bioinformatics research. Annotation data available on Genome Browser includes both internally created and maintained tracks as well as custom tracks and track hubs provided by the research community. This last year's updates include over 25 new annotation tracks such as the gnomAD 4.1 track on the human GRCh38/hg38 assembly, the addition of three new public hubs, and significant expansions to the Genome Archive[GenArk) system for interacting with the enormous variety of assemblies. We have also made improvements to our interface, including updates to the browser graphic page, such as a new popup dialog feature that now displays item details without requiring navigation away from the main Genome Browser page. GenePred tracks have been upgraded with right-click options for zooming and precise navigation, along with enhanced mouseOver functions. Additional improvements include a new grouping feature for track hubs and hub description info links. A new tutorial focusing on Clinical Genetics has also been added to the UCSC Genome Browser.

24 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
LNLuis R Nassar
Luis R Nassar
GBGalt P Barber
Galt P Barber
ABAnna Benet-Pagès
Anna Benet-Pagès
JCJonathan Casper
Jonathan Casper
HCHiram Clawson
Hiram Clawson
WKW James Kent
W James Kent
The UCSC Genome Browser (https://genome.ucsc.edu) is an omics data consolidator, graphical viewer, and general bioinformatics resource that continues to serve the community as it enters its 23rd year. This year has seen an emphasis in clinical data, with new tracks and an expanded Recommended Track Sets feature on hg38 as well as the addition of a single cell track group. SARS-CoV-2 continues to remain a focus, with regular annotation updates to the browser and continued curation of our phylogenetic sequence placing tool, hgPhyloPlace, whose tree has now reached over 12M sequences. Our GenArk resource has also grown, offering over 2500 hubs and a system for users to request any absent assemblies. We have expanded our bigBarChart display type and created new ways to visualize data via bigRmsk and dynseq display. Displaying custom annotations is now easier due to our chromAlias system which eliminates the requirement for renaming sequence names to the UCSC standard. Users involved in data generation may also be interested in our new tools and trackDb settings which facilitate the creation and display of their custom annotations.

11 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BRBrian J Raney
Brian J Raney
GBGalt P Barber
Galt P Barber
ABAnna Benet-Pagès
Anna Benet-Pagès
JCJonathan Casper
Jonathan Casper
HCHiram Clawson
Hiram Clawson
MHMaximilian Haeussler
Maximilian Haeussler
The UCSC Genome Browser (https://genome.ucsc.edu) is a web-based genomic visualization and analysis tool that serves data to over 7,000 distinct users per day worldwide. It provides annotation data on thousands of genome assemblies, ranging from human to SARS-CoV2. This year, we have introduced new data from the Human Pangenome Reference Consortium and on viral genomes including SARS-CoV2. We have added 1,200 new genomes to our GenArk genome system, increasing the overall diversity of our genomic representation. We have added support for nine new user-contributed track hubs to our public hub system. Additionally, we have released 29 new tracks on the human genome and 11 new tracks on the mouse genome. Collectively, these new features expand both the breadth and depth of the genomic knowledge that we share publicly with users worldwide.

18 November 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
JCJonathan Casper
Jonathan Casper
MSMatthew L Speir
Matthew L Speir
BRBrian J Raney
Brian J Raney
GPGerardo Perez
Gerardo Perez
LNLuis R Nassar
Luis R Nassar
MHMaximilian Haeussler
Maximilian Haeussler
Now in its 25th year of operation, the UCSC Genome Browser (https://genome.ucsc.edu) provides a central location for researchers around the world to display and compare annotations on assembled genomes. Highlighted updates include a positional heatmap display, used to show data on functional consequences of mutation from MaveDB; QuickLift, a tool to copy annotation data seen on one assembly for display on another related assembly; and HubSpace, an initiative to simplify the process of creating and using track hubs by providing each user account with dedicated storage on UCSC’s infrastructure.

7 January 2025 in Genetics in Medicine Open
Verified
Journal Article
Open access
ABAnna Benet-Pagès
Anna Benet-Pagès
ALAndreas Laner
Andreas Laner
LNLuis R. Nassar
Luis R. Nassar
TWTobias Wohlfrom
Tobias Wohlfrom
VSVerena Steinke-Lange
Verena Steinke-Lange
MHMGZ - Elke Holinski-Feder
MGZ - Elke Holinski-Feder
Variants of uncertain significance (VUS) are considered one of the most significant impediments to the translation of genetic test results into precise clinical recommendations. The 2015 American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) classification guidelines established a general framework for the assessment and classification of genetic variants; yet, gene-specific specifications are needed to enable better variant classification to reduce the number of VUS. The process of gene-specific adaptations of the ACMG/AMP codes is led and accompanied by ClinGen and implemented by Variant Curation Expert Panels (VCEP). The Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) VCEP recently published its specifications for the BRCA1 (HGNC:1100) and BRCA2 (HGNC:1101) genes. We investigated the differences in reclassification between the ENIGMA specifications and the standard ACMG/AMP classification system in a clinical setting. We reclassified 121 VUS identified in these genes with the latest annotation data using the standard ACMG/AMP classification system and recommendations from the Sequence Variant Interpretation and the ENIGMA specifications. To simplify the reevaluation process, we have created a University of California Santa Cruz Genome Browser track hub that displays the exact data points required for variant classification using the ENIGMA VCEP specifications at the exon and variant level (https://genome.ucsc.edu/s/abenet/BRCA.ENIGMA.hg19). By comparing the codes used and their different weighting in the 2 approaches, we were able to demonstrate the superiority of the application of ENIGMA VCEP specifications, which resulted in a dramatic reduction of VUS (83.5% ENIGMA VCEP vs 20% ACMG/AMP + Sequence Variant Interpretation). For the diagnostic analysis of the BRCA1 and BRCA2 genes, the use of the ENIGMA VCEP specifications gives the best possible result in the clinical translation of genetic variants. The University of California Santa Cruz Genome Browser BRCA1/BRCA2 ENIGMA track set significantly simplified the interpretation process.

4 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
JFJason D. Fernandes
Jason D. Fernandes
AHAngie S. Hinrichs
Angie S. Hinrichs
HCHiram Clawson
Hiram Clawson
JGJairo Navarro Gonzalez
Jairo Navarro Gonzalez
BLBrian T. Lee
Brian T. Lee
MHMaximilian Haeussler
Maximilian Haeussler
Background: Researchers are generating molecular data pertaining to the SARS-CoV-2 RNA genome and its proteins at an unprecedented rate during the COVID-19 pandemic. As a result, there is a critical need for rapid and continuously updated access to the latest molecular data in a format in which all data can be quickly cross-referenced and compared. We adapted our genome browser visualization tool to the viral genome for this purpose. Molecular data, curated from published studies or from database submissions, are mapped to the viral genome and grouped together into “annotation tracks” where they can be visualized along the linear map of the viral genome sequence and programmatically downloaded in standard format for analysis. Results: The UCSC Genome Browser for SARS-CoV-2 ( https://genome.ucsc.edu/covid19.html ) provides continuously updated access to the mutations in the many thousands of SARS-CoV-2 genomes deposited in GISAID and the international nucleotide sequencing databases, displayed alongside phylogenetic trees. These data are augmented with alignments of bat, pangolin, and other animal and human coronavirus genomes, including per-base evolutionary rate analysis. All available annotations are cross-referenced on the virus genome, including those from major databases (PDB, RFAM, IEDB, UniProt) as well as up-to-date individual results from preprints. Annotated data include predicted and validated immune epitopes, promising antibodies, RT-PCR and sequencing primers, CRISPR guides (from research, diagnostics, vaccines, and therapies), and points of interaction between human and viral genes. As a community resource, any user can add manual annotations which are quality checked and shared publicly on the browser the next day. Conclusions: We invite all investigators to contribute additional data and annotations to this resource to accelerate research and development activities globally. Contact us at genome-www@soe.ucsc.edu with data suggestions or requests for support for adding data. Rapid sharing of data will accelerate SARS-CoV-2 research, especially when researchers take time to integrate their data with those from other labs on a widely-used community browser platform with standardized machine-readable data formats, such as the SARS-CoV-2 Genome Browser.